NanoViricides, Inc. (NASDAQ:NNVC) | WebDisclosure

Basculer en Français

9560	Companies
188848	Keywords
120587	Articles
100788	Press releases

Home
Companies
NanoViricides, Inc.

PRESS RELEASE

published on 09/30/2024 at 12:30, 1 year 2 months ago

NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID
NanoViricides, Inc. reports filing of Annual Report on Form 10-K for fiscal year 2024, financial updates, and plans for Phase II clinical trials of antiviral drug NV-387

NanoViricides NV-387 Financial Updates Form 10-K Phase II Clinical Trials
BRIEF

published on 09/26/2024 at 12:35, 1 year 2 months ago

NanoViricides Signs Comprehensive Antiviral Drug Agreement With TheraCour Pharma

NanoViricides NV-387 Antiviral Drugs TheraCour Pharma Trojan Horse Drugs
BRIEF

published on 09/26/2024 at 12:35, 1 year 2 months ago

NanoViricides signe un accord global sur les médicaments antiviraux avec TheraCour Pharma

NanoViricides NV-387 Médicaments Antiviraux TheraCour Pharma Drogues Du Type Cheval De Troie
PRESS RELEASE

published on 09/26/2024 at 12:30, 1 year 2 months ago

NanoViricides Executes an Agreement Encompassing All Antiviral Drug Treatments With Theracour, Including “Trojan Horse” Drugs
NanoViricides, Inc. obtains right of first refusal for antiviral drug developments from TheraCour Pharma, expands drug portfolio with new MOU and revolutionary nanoviricide technology, including NV-387 for multiple viral infections

NV-387 Antiviral Drugs NanoViricides Inc. TheraCour Pharma Nanoviricide Technology
BRIEF

published on 08/26/2024 at 13:35, 1 year 3 months ago

NanoViricides Investigates NV-387 for MPOX Treatment Under WHO's MEURI Protocol

NanoViricides NV-387 Mpox WHO MEURI Protocol
BRIEF

published on 08/26/2024 at 13:35, 1 year 3 months ago

NanoViricides étudie le NV-387 pour le traitement du MPOX dans le cadre du protocole MEURI de l'OMS

NanoViricides NV-387 Mpox Protocole MEURI OMS
PRESS RELEASE

published on 08/26/2024 at 13:30, 1 year 3 months ago

MPOX is Emerging as a Global Threat - NanoViricides Investigating MEURI Protocol for Using NV-387 to Treat MPOX
NanoViricides, Inc. reports investigating NV-387 for MPOX treatment under WHO MEURI protocol amidst 2024 outbreak. NV-387 shows promise in animal studies for broad-spectrum antiviral use

NanoViricides NV-387 Broad-spectrum Antiviral MPOX Treatment WHO MEURI Protocol
BRIEF

published on 08/19/2024 at 12:35, 1 year 4 months ago

NanoViricides Advances Towards Phase II Trial of NV-387

NanoViricides NV-387 Antiviral Therapy Phase II Trial RSV, COVID, Influenza
BRIEF

published on 08/19/2024 at 12:35, 1 year 4 months ago

NanoViricides avance vers la phase II de l'essai du NV-387

NanoViricides NV-387 Essai De Phase II Thérapie Antivirale VRS, COVID, Grippe
PRESS RELEASE

published on 08/19/2024 at 12:30, 1 year 4 months ago

NanoViricides Continues Its March Towards a Phase II Clinical Trial of NV-387 - A Potentially Revolutionary First Line Antiviral Therapy for RSV, COVID, and Other Viral Infections
NanoViricides, Inc. provides update on Phase II clinical trial plans for broad-spectrum antiviral drug candidate NV-387 against RSV, COVID, and Influenza. Potential $12 Billion market. Novel trial design expected

NanoViricides NV-387 Clinical Trial Antiviral Phase II

Accesswire

Published on 12/20/2025 at 00:30, 1 day 6 hours ago

Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 1 day 9 hours ago

GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 1 day 12 hours ago

Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 1 day 16 hours ago

Northern Superior Announces Closing of the Arrangement
Published on 12/19/2025 at 13:30, 1 day 17 hours ago

Quartz Commences Trading On The OTCQX Best Market Under The Symbol QZMRF

View all ACCESSWIRE

EQS Group

Published on 12/20/2025 at 16:45, 14 hours 21 minutes ago

Shanghai Electric Powers Up Iraq's Energy Future with Major 625MW Efficiency Upgrade
Published on 12/20/2025 at 10:05, 21 hours 1 minute ago

FITUR 2026 highlights the strong synergies between Germany and Spain
Published on 12/19/2025 at 22:03, 1 day 9 hours ago

EAMD: Trading resumes on the Düsseldorf Stock Exchange, lawsuit filed by minority shareholders dismissed, capital increase for investments in drone projects in the defense tech sector
Published on 12/19/2025 at 21:40, 1 day 9 hours ago

IMG Saxony-Anhalt: 2026 in Sight - Saxony-Anhalt Sets the Pace for Future Industries
Published on 12/19/2025 at 20:35, 1 day 10 hours ago

Nobu Manchester breaks ground as Robert De Niro visits Manchester with Salboy

Les Echos

Published on 12/19/2025 at 21:57, 1 day 9 hours ago

Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 1 day 22 hours ago

Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 1 day 22 hours ago

Réduction du capital par voie d’annulation d’actions propres
Published on 12/19/2025 at 07:00, 2 days ago

EURAZEO ANNONCE AVOIR MENÉ AVEC SUCCÈS UNE TRANSACTION ACCÉLÉRANT SA ROTATION D'ACTIFS
Published on 12/19/2025 at 07:00, 2 days ago

EURAZEO ANNOUNCES A SUCCESSFUL TRANSACTION ACCELERATING ITS ASSET ROTATION

View all LES ECHOS COMFI WIRE